- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 22 - Antiplatelet Agents Explored
Because of recently updated recommendations by the American College of Cardiology Foundation and American Heart Association about how to treat patients with cardiovascular disorders with antiplatelet therapy, Michael Weber, MD, discusses his personal recommendations.
Kenneth L. Schaecher, MD, FACP, CPC, briefly explains both the clinical and economic outcomes demonstrated through treatment with these agents, and because a large number of antiplatelet drugs are developing, David Calabrese, RPh, MHP, discusses how newer agents address treatment gaps and have better economic value when compared to older agents.
Although Dr Schaecher agrees with the potential of these new drugs, he concludes that there are still many unanswered questions about the ability of these agents to treat patients at risk for developing cardiometabolic events.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
No Major Shifts in OBGYN Practice Locations Found Post Dobbs Decision
April 21st 2025Despite widespread concern following the Dobbs v Jackson Women’s Health Organization decision, researchers found no significant changes nationwide in obstetrician and gynecologist (OBGYN) practice locations.
Read More
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More
